Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 362814, 5 pages
http://dx.doi.org/10.1155/2014/362814
Clinical Study

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients

1Department of Surgery, Section of Urology, Charlie Norwood Veteran’s Administration Medical Center, Augusta, GA 30904, USA
2Department of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA
3Section of Surgery, Division of Urology, Durham Veteran’s Administration Medical Center, Durham, NC 27705, USA
4Departments of Surgery and Pathology, Division of Urology, Duke University School of Medicine, Durham, NC 27710, USA
5Department of Urologic Surgery, Vanderbilt University, A-1302 Medical Center North, Nashville, TN 37232, USA

Received 10 May 2014; Revised 14 June 2014; Accepted 15 June 2014; Published 24 August 2014

Academic Editor: R. Jeffrey Karnes

Copyright © 2014 Zachary Klaassen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. R. Cooperberg, J. Cowan, J. M. Broering, and P. R. Carroll, “High-risk prostate cancer in the United States, 1990–2007,” World Journal of Urology, vol. 26, no. 3, pp. 211–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. V. D'Amico, R. Whittington, S. B. Malkowicz et al., “Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer,” The Journal of the American Medical Association, vol. 280, no. 11, pp. 969–974, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. H. B. Carter, P. C. Albertsen, M. J. Barry et al., “Early detection of prostate cancer: AUA guideline,” Journal of Urology, vol. 190, no. 2, pp. 419–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. Charlson, P. Pompei, K. A. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Chornokur, K. Dalton, M. E. Borysova, and N. B. Kumar, “Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer,” The Prostate, vol. 71, no. 9, pp. 985–997, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. F. Sanchez-Ortiz, P. Troncoso, R. J. Babaian, J. Lloreta, D. A. Johnston, and C. A. Pettaway, “African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men,” Cancer, vol. 107, no. 1, pp. 75–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Schwartz, I. J. Powell, W. Underwood III, J. George, C. Yee, and M. Banerjee, “Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer,” Urology, vol. 74, no. 6, pp. 1296–1302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. A. Moses, A. T. Paciorek, D. F. Penson, P. R. Carroll, and V. A. Master, “Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE,” Journal of Clinical Oncology, vol. 28, no. 6, pp. 1069–1074, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Caire, L. Sun, T. J. Polascik, D. M. Albala, and J. W. Moul, “Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans,” BJU International, vol. 106, no. 8, pp. 1157–1160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. A. Barocas, D. T. Gray, J. H. Fowke et al., “Racial variation in the quality of surgical care for prostate cancer,” Journal of Urology, vol. 188, no. 4, pp. 1279–1285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. L. Krupski, A. Fink, L. Kwan et al., “Health-related quality-of-life in low-income, uninsured men with prostate cancer,” Journal of Health Care for the Poor and Underserved, vol. 16, no. 2, pp. 375–390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Underwood, S. DeMonner, P. Ubel, A. Fagerlin, M. G. Sanda, and J. T. Wei, “Racial/ethnic disparities in the treatment of localized/regional prostate cancer,” Journal of Urology, vol. 171, no. 4, pp. 1504–1507, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Gilligan, “Social disparities and prostate cancer: mapping the gaps in our knowledge,” Cancer Causes and Control, vol. 16, no. 1, pp. 45–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Sammon, M. Morgan, O. Djahangirian et al., “Marital status: a gender-independent risk factor for poorer survival after radical cystectomy,” BJU International, vol. 110, no. 9, pp. 1301–1309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. S. Pruthi, A. C. Lentz, M. Sand, E. Kouba, and E. M. Wallen, “Impact of marital status in patients undergoing radical cystectomy for bladder cancer,” World Journal of Urology, vol. 27, no. 4, pp. 573–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Gore, L. Kwan, C. S. Saigal, and M. S. Litwin, “Marriage and mortality in bladder carcinoma,” Cancer, vol. 104, no. 6, pp. 1188–1194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Abdollah, M. Sun, R. Thuret et al., “The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study,” Cancer Causes and Control, vol. 22, no. 8, pp. 1085–1095, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Roach III, G. Hanks, H. Thames Jr. et al., “Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference,” International Journal of Radiation Oncology Biology Physics, vol. 65, no. 4, pp. 965–974, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. A. Antonelli, L. W. Jones, L. L. Bañez et al., “Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy,” The Journal of Urology, vol. 182, no. 5, pp. 2226–2231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Antonelli, S. J. Freedland, and L. W. Jones, “Exercise therapy across the prostate cancer continuum,” Prostate Cancer and Prostatic Diseases, vol. 12, no. 2, pp. 110–115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Extermann, “Interaction between comorbidity and cancer,” Cancer Control, vol. 14, no. 1, pp. 13–22, 2007. View at Google Scholar · View at Scopus
  23. E. H. Allott, E. M. Masko, and S. J. Freedland, “Obesity and prostate cancer: weighing the evidence,” European Urology, vol. 63, no. 5, pp. 800–809, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Braithwaite, D. H. Moore, W. A. Satariano et al., “Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study,” Cancer Epidemiology Biomarkers & Prevention, vol. 21, no. 7, pp. 1115–1125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Lund, M. Borre, J. Jacobsen, H. T. Sørensen, and M. Nørgaard, “Impact of comorbidity on survival of Danish prostate cancer patients. 1995–2006: a population-based cohort study,” Urology, vol. 72, no. 6, pp. 1258–1262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. W. S. Kendal, “Dying with cancer: the influence of age, comorbidity, and cancer site,” Cancer, vol. 112, no. 6, pp. 1354–1362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Briganti, M. Spahn, S. Joniau et al., “Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis,” European Urology, vol. 63, no. 4, pp. 693–701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. Rider, F. Sandin, O. Andrén, P. Wiklund, J. Hugosson, and P. Stattin, “Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study,” European Urology, vol. 63, no. 1, pp. 88–96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. J. R. Lieffers, V. E. Baracos, M. Winget, and K. Fassbender, “A comparison of charlson and elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data,” Cancer, vol. 117, no. 9, pp. 1957–1965, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Nemes, J. M. Jonasson, A. Genell, and G. Steineck, “Bias in odds ratios by logistic regression modelling and sample size,” BMC Medical Research Methodology, vol. 9, no. 1, article 56, 2009. View at Publisher · View at Google Scholar · View at Scopus